Similar Posts
Despite evidence of FBI bungling, new probe into anthrax killings unlikely/ ProPublica
From Pro Publica: A senior Republican senator says it would take a powerful grassroots movement or startling new evidence to reopen the Justice Department’s investigation that branded a now-deceased Army researcher as the anthrax mailer who killed five people a decade ago. Iowa Sen. Charles Grassley, the ranking Republican on the Senate Judiciary Committee, and…
I and many others suggested in the first half of 2020 that it was likely SARS-CoV-2 was created as a chimera of bat viruses and passaged in humanized mice. Seems like we were right
https://theintercept.com/2021/10/01/nih-bat-coronavirus-grant-ecohealth-alliance/ NIH BAT CORONAVIRUS GRANT REPORT WAS SUBMITTED MORE THAN TWO YEARS LATE The unusual timing of a bat coronavirus grant report suggests that an earlier version may have been revised. The annual report described the group’s work from June 2017 to May 2018, which involved creating new viruses using different parts of existing bat…
My talk to the World Freedom Alliance conference in Copenhagen, November 26, 2021
This talk was about: a) similarities between the anthrax letters and the COVID pandemic, and b) identifying and investigating the obvious perpetrators, the foot soldiers of the cabal to institute a great reset. This is a major vulnerability of the cabal. Shine a spotlight on the perpetrators, and soon the cabal won’t have so many…
Internal audit slams DHS for canceling technology to fight bio-threats/ WaPo
And another story about an inexplicable contracting decision regarding a biodefense product, in today’s WaPo: Last year, a Silicon Valley start-up came close to producing what government scientists considered a breakthrough technology — a device the size of a ski boot that could test for tiny microorganisms at rapid speed, helping to safeguard the nation…
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data/ BMJ
https://blogs.bmj.com/bmj/2020/11/26/peter-doshi-pfizer-and-modernas-95-effective-vaccines-lets-be-cautious-and-first-see-the-full-data/ November 26, 2020 Only full transparency and rigorous scrutiny of the data will allow for informed decision making, argues Peter Doshi In the United States, all eyes are on Pfizer and Moderna. The topline efficacy results from their experimental covid-19 vaccine trials are astounding at first glance. Pfizer says it recorded 170 covid-19 cases…
The coronavirus’s origins are still a mystery. We need a full investigation/ WaPo Editorial
The tide is turning. The origin of SARS-CoV-2 remains in question. And now the WaPo is supporting a full investigation, below. But don’t expect much from pending investigations by the WHO or a group that has constituted itself as from the Lancet. The Lancet group’s origin investigation is being led by Peter Daszac, PhD, whose…